| HPLC | Methanol | Mobile phase A: methanol:KH2PO4:triethylamine (30:69.7:0.3); mobile phase B: acetonitrile | 277 | [37] | ||
| HPLC | Methanol | Mobile phase A: KH2PO4:octanesulfonic acide (5:1) phase B: acetonitrile (Phase B) | 310 | [39] | ||
| HPLC | KH2PO4:methanol (2:8) | KH2PO4:methanol (3:7) | 400 | [38] | ||
| Enrofloxacin | 1 | HPLC | KH2PO4:Acetonitrile (75:25) | acetonitrile:KH2PO4 (75:25) | 267 | [59] |
| Gatifloxacin | 2 | HPLC | Buffer citrate:acetonitrile (52:48) | buffer citrate:acetonitrile (52:48) | 292 | [53] |
| Spectro | Water | 412, 415, 417, 414 | [23] | |||
| Gemifloxacin | 1 | Spectro | Methanol | 270 | [30] | |
| Imipenem | 1 | HPLC | methanol:water (50:50) | methanol:orthophosphoric acid (60:40) | 225 | [26] |
| Spectro | Water | 525 | ||||
| Josamycin | 1 | HPLC | acetonitrile:water (3:7) | acetonitrile:buffer phosphate:hydrogeno sulfate tetrabutylammonium:water (21:5:3:71) | 232 | [44] |
| Levofloxacin | 1 | HPLC | acetonitrile:water (1:1) | water:acetonitrile (6:5) | 260, 265, 270, 275, 280 | [60] |
| Lincomycin | 1 | HPLC | Ethanol | acetonitrile:buffer phosphate (89:11) | 220 | [61] |
| Meropenem | 1 | HPLC | Water | KH2PO4:acetonitrile (9:1) | 298,0 | [32] |
| Spectro | Water | 298,0 | ||||
| Metronidazole | 2 | HPLC | KHPO4 | KHPO4:methanol (95:5) | 254 | [36] |
| HPLC | acetonitrile:methanol (80:20) | NaHPO4:acetonitrile (65:35) | 319 | [51] | ||
| Moxifloxacin | 4 | HPLC | Methanol | methanol:KH2PO4 (62:38) | 254 | [42] |
| Spectro | Water | 623, 660 | [24] | |||
| HPLC | acide phosphorique 0.1% | water (triethlyamine2%):acetonitrile (90:10) | 290 | [41] | ||
| Spectro | 1) HCl 0.1 N 2) tampon phosphate | 296, 289 | [33] | |||
| Norfloxacine | 1 | HPLC | Methanol | Mobile phase A: KH2PO4:octanesulfonic acid (5:1) phase B: acetonitrile (Phase B) | 310 | [39] |
| Oxytetracyclin | 2 | HPLC | HCl 0.01 M | Phase A: 0.05% trifluoroacetic acid in water; phase B: acetonitrile:methanol:tetrahydrofuran (80:15:5) | 254 | [49] |
| HPLC | Methanol | methanol:acetonitrile:buffer phosphate (12.5:12.5:75) | 253 | [52] | ||
| Rifampicine | 1 | HPLC | acetonitrile:KH2PO4 (50:50) | acetonitrile:KH2PO4 (50:50) | 238 | [62] |
| Roxithromycin | 1 | HPLC | Ethanol | KH2PO4:acetonitrile (50:50) | 205 | [63] |
| Spectinomycin | 1 | HPLC | acetonitrile:tampon phosphate (89:11) | acetonitrile:buffer phosphate (89:11) | 220 | [61] |
| Tinidazole | 1 | HPLC | Methanol | Mobile phase A: KH2PO4:acide octanesulfonic acid (5:1) phase B: acetonitrile (Phase B) | 310 | [39] |